Madison Asset Management, LLC Glaukos Corp Transaction History

Madison Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$47.43 - $84.23 $997,026 - $1.77 Million	-21,021 Closed	0 $0
Q2 2021 Aug 09, 2021	SELL	$73.06 - $97.7 $1.52 Million - $2.03 Million	-20,743 Reduced 49.67%	21,021 $1.78 Million
Q1 2021 May 11, 2021	SELL	$70.43 - $97.42 $1.78 Million - $2.46 Million	-25,290 Reduced 37.72%	41,764 $3.51 Million
Q4 2020 Feb 12, 2021	BUY	$48.9 - $75.26 $181,565 - $279,440	3,713 Added 5.86%	67,054 $5.05 Million
Q3 2020 Nov 12, 2020	SELL	$37.23 - $50.97 $417,162 - $571,118	-11,205 Reduced 15.03%	63,341 $3.14 Million
Q2 2020 Aug 13, 2020	BUY	$28.78 - $46.83 $1.34 Million - $2.18 Million	46,654 Added 167.27%	74,546 $2.86 Million
Q1 2020 May 12, 2020	BUY	$25.53 - $70.14 $712,082 - $1.96 Million	27,892 New	27,892 $861,000

303

47M

75.3K

157K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $6.2B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Madison Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Madison Asset Management, LLC with notifications on news.